Oncovision will be very present at this year’s SABCS, with a booth and 3 groundbreaking scientific presentations on the Mammi dedicated breast PET. This is the first year that Mammi db PET has FDA approval for sale in the US, so we are anticipating a big interest in learning more about our technology. Come see why Mamma dbPET is taking MOLECULAR BREAST IMAGING to new heights due to its extremely high sensitivity and specificity combined with short scan times. So don´t miss these presentations:

Improving specificity and refining diagnostic accuracy of MRI in breast cancer with dedicated breast PET (dbPET).  Prof. Michel Herranz

Dedicated breast PET (dbPET) a unique functional new tool to accurate quantify response to neoadjuvant therapy in breast cancer.  Prof. Michel Herranz

Visualisation of histologic proven breast cancer on the MAMMI dbPET:   a dedicated PET for hanging breast imaging.  Dr. Suzana Teixeira

Please visit us at Booth 458